Robert Musslewhite

Robert Musslewhite is Chairman of the Governors Board at St. Albans School since 2013.
He is an Independent Director at CoStar Group, Inc. since 2019.
He serves as Director at Ascend Learning LLC since 2018, Miriam’s Kitchen, ADC Therapeutics America, Inc. since 2023, and Iodine Software LLC since 2022.
He is an Independent Director at Cardinal Health, Inc. starting in 2025.
He is a Member of The Economic Club of Washington and a Member of the Young Presidents' Organization (Washington) local chapter.
Formerly, Mr. Musslewhite was Chairman and Chief Executive Officer of The Advisory Board Co. from 2013 to 2017 and of The Advisory Board Co. (United Kingdom) from 2017 to 2019.
He was Chief Executive Officer of OptumInsight, Inc. from 2019 to 2022 and of Optum360 LLC in 2019.
He was President and Chief Executive Officer of Lundbeck Seattle BioPharmaceuticals, Inc. from 2018 to 2019 and of Climb Bio, Inc. from 2020 to 2023.
He was Chief Executive Officer and Director of Definitive Healthcare Corp.
from 2022 to 2024 and President and Director of Definitive Healthcare LLC from 2021 to 2022.
He was Chief Commercial Officer and Executive Vice President of Juno Therapeutics, Inc. from 2015 to 2018.
He was Director at Evolent Health, Inc. from 2011 to 2016 and at Clovis Oncology, Inc. from 2018 to 2022.
He was Associate Principal at McKinsey & Co., Inc. from 1997 to 2003.
He held Director roles at SNL Financial LC, Chinook Therapeutics, Inc., Autolus Therapeutics Plc, and Immunomedics, Inc. Education includes an undergraduate degree from Princeton University conferred in 1992 and a graduate degree from Harvard Law School conferred in 1996.